enow.com Web Search

  1. Ads

    related to: new diabetes medication

Search results

  1. Results from the WOW.Com Content Network
  2. FDA approves generic in same class as Ozempic for diabetes ...

    www.aol.com/news/fda-approves-generic-same-class...

    The Food and Drug Administration has just approved a generic form of a type 2 diabetes drug in the same class as Ozempic. It's too soon to tell, but it might help reduce the price of these drugs ...

  3. There’s still no generic Ozempic, but a lower-priced daily ...

    www.aol.com/news/still-no-generic-ozempic-lower...

    The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

  4. FDA approves new version of diabetes drug Mounjaro for weight ...

    www.aol.com/fda-approves-version-diabetes-drug...

    Zepbound, a new version of the company’s popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday, Nov. 8, 2023. (AP Photo/Darron Cummings, File)

  5. Dapagliflozin/sitagliptin - Wikipedia

    en.wikipedia.org/wiki/Dapagliflozin/sitagliptin

    This pharmacology -related article is a stub. You can help Wikipedia by expanding it.

  6. Why Doctors Are Calling This Common Medication a ... - AOL

    www.aol.com/why-doctors-calling-common...

    In fact, new research found it may help to lower the risk of long COVID in patients with type 2 diabetes. Long COVID is just the most recent finding of the drug's possible benefits.

  7. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    Drugs used in diabetes treat diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin , most GLP-1 receptor agonists ( liraglutide , exenatide , and others), and pramlintide , all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents.

  1. Ads

    related to: new diabetes medication